This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Julia Vennekamp: Innovator in Potassium Channel Inhibition
Introduction
Julia Vennekamp is a notable inventor based in Kiel, Germany. She has made significant contributions to the field of medical science, particularly in the development of compounds that inhibit potassium channel activity. Her work has implications for treating various diseases, including autoimmune disorders.
Latest Patents
Julia Vennekamp holds 1 patent for her invention titled "Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells." This patent describes compositions of matter comprising 5-phenylalkoxypsoralen compounds and their method of synthesis and use. The compounds are designed to treat diseases or disorders in both human and veterinary patients, including autoimmune diseases such as multiple sclerosis. The therapeutic effects of these compounds may be attributed to their ability to inhibit potassium channels, particularly the Kv1.3 channel.
Career Highlights
Julia Vennekamp is affiliated with the University of California, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the study of potassium channels and their role in various medical conditions.
Collaborations
Some of her notable coworkers include Heike Wulff and K. George Chandy. Their collaborative efforts have further advanced the understanding of potassium channel inhibition and its therapeutic potential.
Conclusion
Julia Vennekamp's contributions to the field of potassium channel inhibition represent a significant advancement in medical science. Her innovative compounds hold promise for treating serious autoimmune diseases, showcasing the impact of her research on healthcare.